BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3080231)

  • 1. In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system.
    Magae J; Suzuki S; Nagai K; Yamasaki M; Ando K; Tamura G
    Cancer Res; 1986 Mar; 46(3):1073-8. PubMed ID: 3080231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
    Umiel T; Pecht M; Trainin N
    J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of anticonvulsants on cellular immunity].
    Okamoto Y; Shimizu K; Tamura K; Yamada M; Matsui Y; Hayakawa T; Mogami H
    No To Shinkei; 1989 Mar; 41(3):299-304. PubMed ID: 2503016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS; Malek TR; Hargrove ME; Ting CC
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pyocyanine, a blue pigment from Pseudomonas aeruginosa, on separate steps of T cell activation: interleukin 2 (IL 2) production, IL 2 receptor formation, proliferation and induction of cytolytic activity.
    Mühlradt PF; Tsai H; Conradt P
    Eur J Immunol; 1986 Apr; 16(4):434-40. PubMed ID: 2422042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of radiation on the production of interleukins and T-lymphocyte activities.
    Manori I; Kushelevsky A; Segal S; Weinstein Y
    J Natl Cancer Inst; 1985 Jun; 74(6):1215-21. PubMed ID: 3923245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
    Griswold DE; Lee JC; Poste G; Hanna N
    J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive and enhancing effect of T-2 toxin on murine lymphocyte activation and interleukin 2 production.
    Holt PS; Corrier DE; DeLoach JR
    Immunopharmacol Immunotoxicol; 1988; 10(3):365-85. PubMed ID: 3264300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (IL-2) and interleukin-1 beta (IL-1 beta) in mice splenocytes].
    Arias J; Melean E; Valero N; Pons H; Chacín-Bonilla L; Larreal Y; Bonilla E
    Invest Clin; 2003 Mar; 44(1):41-50. PubMed ID: 12703182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
    Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory mechanisms of arginine.
    Reynolds JV; Daly JM; Zhang S; Evantash E; Shou J; Sigal R; Ziegler MM
    Surgery; 1988 Aug; 104(2):142-51. PubMed ID: 2840748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
    Palacios R
    J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of DTC and zinc supplementation on the cellular response restoration in restrained mice.
    Obminska-Mrukowicz B; Szczypka M
    J Vet Sci; 2005 Mar; 6(1):25-32. PubMed ID: 15785120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.